Effect of disulfiram eye drops on lipid peroxide formation via excessive nitric oxide in lenses of hereditary cataract ICR/f rats

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 5, 2008, Pages 981-985

  Nagai, Noriaki ^a   Ito, Yoshimasa ^a   Takeuchi, Noriko ^b  

^a KINKI UNIVERSITY   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Cataract; Disulfiram; ICR f rat; Lipid peroxide; Nitric oxide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; DISULFIRAM; EYE DROPS; LIPID PEROXIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; ENZYME ACTIVITY; LENS; NONHUMAN; RAT;

ALCOHOL DETERRENTS; ANIMALS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CATARACT; CYCLODEXTRINS; DISULFIRAM; EYE PROTEINS; LENS, CRYSTALLINE; LIPID PEROXIDES; NITRIC OXIDE; OPHTHALMIC SOLUTIONS; RATS;

EID: 44349108345     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.981     Document Type: Article

References (31)

1. Schreck R., Meier B., Mannel, D. N., Droge W., Baeuerle P. A., J. Exp. Med., 175, 1181-1194 (1992).
2. Mulsch A., Schray-Utz B., Mordvintcev P. I., Hauschildt S., Busse R., FEBS Lett., 321, 215-218 (1993).
3. Kuhnlein U., Biochim. Biophys. Acta, 609, 75-83 (1980).
4. Koster J. F., Van Berkel T. J., Biochem. Pharmacol., 32, 3307-3310 (1983).
5. Ito Y., Cai H., Terao M., Tomohiro M., Ophthalmic Res., 33, 52-59 (2001).
6. Wang S., Li D., Ito Y., Liu X., Zhang J., Wu C., J. Pharm. Pharmacol., 56, 1251-1257 (2004).
7. Ito Y., Cai H., Koizumi Y., Hori R., Terao M., Kimura T., Takagi S., Tomohiro M., Biol. Pharm. Bull., 23, 327-333 (2000).
8. Rall T. W., "The Pharmacological Basis of Therapeutics," 8th ed., ed. by Gilman A. G., Rall T. W., Nies A. S., Taylor P., Perfamon Press, New York, 1990, pp. 378-379.
9. Ito Y., Cai H., Koizumi Y., Nakao M., Terao M., Curr. Eye Res., 18, 292-299 (1999).
10. Nabekura T., Koizumi Y., Nakao M., Tomohiro M., Inomata M., Ito Y., Exp. Eye Res., 76, 169-174 (2003).
11. Irie T., Uekama K., J. Pharm. Sci., 86, 147-162 (1997).
12. Mueller B. W., Brauns U., Int. J. Pharm., 26, 77-88 (1985).
13. Kristinsson J. K., Fridriksdottir H., Thorisdottir S., Sigurdardottir A. M., Stefansson E., Loftsson T., Invest. Ophthalmol. Vis. Sci., 37, 1199-1203 (1996).
14. Nagai N., Takeda M., Ito Y., Takeuchi N., Kamei A., Biol. Pharm. Bull., 30, 1529-1534 (2007).
15. Takeuchi N., Ouchida A., Kamei A., Biol. Pharm. Bull., 27, 308-314 (2004).
16. Kamei A., Takamura S., Nagai M., Takeuchi N., Biol. Pharm. Bull., 27, 1923-1931 (2004).
17. Takeuchi N., Kamei A., Biol. Pharm. Bull., 23, 283-290 (2000).
18. Takeuchi N., Ito H., Namiki K., Kamei A., Biol. Pharm. Bull., 24, 1246-1251 (2001).
19. Wang Z., Bunce G. E., Hess J. L., Curr. Eye Res., 12, 213-218 (1993).
20. Bradford, M. M., Anal. Biochem., 72, 248-254 (1976).
21. Rasi V., Costantini S., Moramarco A., Giordano R., Giustolisi R., Balacco G. C., Ann. Ophthalmol., 24, 459-464 (1992).
22. Duncan G., Bushell A. R., Exp. Eye Res., 20, 223-230 (1975).
23. Hightower K. R., Reddy V. N., Exp. Eye Res., 34, 413-421 (1982).
24. Dilsiz N., Olcucu A., Atas M., Cell Biochem. Funct., 18, 259-262 (2000).
25. Carafolie E., J. Biol. Chem., 267, 2115-2118 (1992).
26. Babizhayev M. A., Biochim. Biophys. Acta, 1315, 87-99 (1996).
27. Borchman D., Paterson C. A., Delamere N. A., Invest. Ophthalmol. Vis. Sci., 30, 1633-1637 (1989).
28. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A., Proc. Natl. Acad. Sci. U.S.A., 87, 1620-1624 (1990).
29. Beckman J. S., Crow J. P., Biochem. Soc. Trans., 21, 330-334 (1993).
30. Radi R., Beckman J. S., Bush K. M., Freeman B. A., Arch. Biochem. Biophys., 288, 481-487 (1991).
31. Ibaraki N., Chen S. C., Lin L. R., Okamoto H., Pipas J. M., Reddy V. N., Exp. Eye Res., 67, 577-585 (1998).